Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 14 04:00PM ET
1.35
Dollar change
+0.04
Percentage change
3.05
%
IndexRUT P/E- EPS (ttm)-1.65 Insider Own12.60% Shs Outstand90.55M Perf Week0.00%
Market Cap122.25M Forward P/E- EPS next Y-1.86 Insider Trans0.15% Shs Float79.15M Perf Month-14.01%
Income-148.12M PEG- EPS next Q-0.42 Inst Own59.84% Short Float11.19% Perf Quarter-42.43%
Sales11.47M P/S10.66 EPS this Y-20.17% Inst Trans-11.95% Short Ratio6.01 Perf Half Y-28.95%
Book/sh3.11 P/B0.43 EPS next Y-12.11% ROA-36.94% Short Interest8.86M Perf Year-79.13%
Cash/sh2.52 P/C0.54 EPS next 5Y-12.22% ROE-43.60% 52W Range1.22 - 8.33 Perf YTD-15.09%
Dividend Est.- P/FCF- EPS past 5Y-37.16% ROI-48.30% 52W High-83.79% Beta2.31
Dividend TTM- Quick Ratio7.38 Sales past 5Y71.11% Gross Margin58.89% 52W Low10.66% ATR (14)0.10
Dividend Ex-Date- Current Ratio7.38 EPS Y/Y TTM-10.11% Oper. Margin-1439.50% RSI (14)40.47 Volatility6.72% 6.23%
Employees158 Debt/Eq0.09 Sales Y/Y TTM-66.85% Profit Margin-1290.81% Recom1.44 Target Price13.25
Option/ShortYes / Yes LT Debt/Eq0.09 EPS Q/Q-221.11% Payout- Rel Volume0.80 Prev Close1.31
Sales Surprise-34.23% EPS Surprise15.48% Sales Q/Q-91.45% EarningsNov 06 AMC Avg Volume1.48M Price1.35
SMA20-3.88% SMA50-18.14% SMA200-35.37% Trades Volume1,173,162 Change3.05%
Date Action Analyst Rating Change Price Target Change
Jun-03-24Downgrade Evercore ISI Outperform → In-line $13 → $3
Nov-08-23Initiated Cantor Fitzgerald Neutral
Oct-31-23Initiated Evercore ISI Outperform $13
Jul-11-23Initiated Truist Buy $23
Feb-18-22Initiated RBC Capital Mkts Outperform $22
Dec-01-21Initiated Oppenheimer Outperform $36
Nov-30-21Initiated H.C. Wainwright Buy $28
Nov-15-21Upgrade Citigroup Neutral → Buy $27
Aug-17-21Initiated SVB Leerink Outperform $32
Aug-17-21Initiated Citigroup Neutral $27
Feb-07-25 05:45AM
Jan-31-25 05:45AM
Jan-24-25 05:45AM
Jan-17-25 05:45AM
Jan-14-25 05:45AM
07:05PM Loading…
Jan-12-25 07:05PM
Jan-07-25 04:00PM
Jan-02-25 08:00AM
Dec-30-24 03:01PM
Dec-16-24 09:55AM
Nov-20-24 04:00PM
Nov-06-24 06:05PM
04:05PM
Oct-31-24 03:53AM
Oct-17-24 03:06PM
09:00AM Loading…
Sep-25-24 09:00AM
Sep-03-24 08:00AM
Aug-26-24 04:00PM
Aug-12-24 08:00AM
Aug-06-24 06:50PM
04:05PM
10:00AM
Jul-17-24 07:45AM
Jul-09-24 08:00AM
Jun-02-24 07:00PM
May-30-24 04:01PM
May-12-24 04:00PM
May-09-24 05:23AM
May-07-24 10:55PM
05:25PM
04:05PM Loading…
04:05PM
May-01-24 04:05PM
Apr-27-24 06:00AM
Apr-24-24 10:00AM
Apr-15-24 09:00AM
Apr-04-24 04:00PM
Mar-14-24 12:00PM
Mar-13-24 03:32PM
Mar-12-24 12:37PM
Mar-11-24 04:05PM
Mar-05-24 04:30PM
Feb-26-24 01:14PM
06:45AM
Feb-23-24 11:25PM
Feb-15-24 04:05PM
Feb-12-24 08:30AM
Jan-15-24 08:45AM
Jan-07-24 11:00AM
Dec-13-23 07:26AM
05:20AM
Dec-12-23 04:02PM
Dec-08-23 12:00PM
Dec-06-23 09:55AM
Nov-20-23 09:55AM
Nov-07-23 04:00PM
Nov-06-23 08:00AM
Nov-01-23 04:05PM
Oct-20-23 05:00AM
Oct-18-23 08:00AM
Oct-11-23 06:00AM
Oct-10-23 05:40AM
Oct-05-23 10:07AM
Sep-27-23 08:30AM
08:00AM
Sep-23-23 08:45AM
Aug-29-23 04:00PM
Aug-24-23 05:58AM
Aug-15-23 04:08PM
03:08PM
Aug-08-23 05:15PM
04:00PM
Jul-28-23 08:30AM
Jul-22-23 09:45AM
Jul-21-23 10:00AM
Jul-20-23 11:35AM
Jul-19-23 09:30AM
Jul-17-23 05:03PM
Jul-14-23 11:27AM
Jul-13-23 11:15PM
04:03PM
04:01PM
04:01PM
09:30AM
Jul-12-23 09:40AM
Jul-11-23 09:55AM
Jul-07-23 08:14AM
Jul-06-23 11:03PM
01:56PM
11:54AM
10:43AM
08:00AM
Jun-15-23 12:53PM
May-31-23 04:00PM
May-16-23 11:25AM
May-09-23 05:15PM
04:00PM
May-08-23 09:00AM
May-01-23 04:00PM
Apr-26-23 02:10PM
Apr-17-23 01:30PM
Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ryali SriramChief Financial OfficerJan 29 '25Buy1.4217,36024,65117,360Jan 30 04:02 PM